news Novel class of targeted cancer therapies could treat myeloid leukaemias 16 December 2020 | By Hannah Balfour (Drug Target Review) Cancer researchers have created a new class of drugs to selectively target and destroy myeloid leukaemia cells with TET gene mutations.